BHLHE41 and nonpapillary renal cell carcinoma: Our results show that in ccRCC tumors, the initial increase in expression of BHLHE41 decreases as the tumor stage progresses, which meets the needs of ccRCC development i.e., the nature of its effect on the tumor changes as it develops.